This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Johnson & Johnson
Drug Names(s): Itraconazole
Description: Sporanox (Itraconazole) Oral Solution/Injection (IV) is a drug for several difficult-to-treat fungal infections including some potentially life-threatening infections that affect individuals with compromised immune systems, such as patients on chemotherapy, those who have undergone a bone marrow or solid organ transplant, and individuals with HIV infection.
Pink Sheet Sporanox Generic Launches
Pink Sheet In Brief: Janssen Sporanox
Pink Sheet Sporanox patent ruling
Additional information available to subscribers only: